{"drugs":["Recothrom","Thrombin Human, Recombinant"],"mono":{"0":{"id":"928972-s-0","title":"Generic Names","mono":"Thrombin Human, Recombinant"},"1":{"id":"928972-s-1","title":"Dosing and Indications","sub":{"0":{"id":"928972-s-1-4","title":"Adult Dosing","mono":"<ul><li>do not inject systemically as that can lead to extensive intravascular clotting and death<\/li><li><b>Control of hemorrhage:<\/b> apply TOPICALLY on the surface of the bleeding tissue with or without an absorbable gelatin sponge; amount required depends upon the area of tissue being treated and the method of application<\/li><\/ul>"},"1":{"id":"928972-s-1-5","title":"Pediatric Dosing","mono":"<ul><li>safety and efficacy not established in pediatric patients less than 1 month of age<\/li><li><b>Control of hemorrhage:<\/b> 1 month or older, apply TOPICALLY on the surface of the bleeding tissue with or without an absorbable gelatin sponge; amount required depends upon the area of tissue being treated and the method of application<\/li><\/ul>"},"3":{"id":"928972-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><br\/>Control of hemorrhage<br\/>"}}},"3":{"id":"928972-s-3","title":"Contraindications\/Warnings","sub":[{"id":"928972-s-3-9","title":"Contraindications","mono":"<ul><li>arterial bleeding, massive or brisk<\/li><li>direct circulatory injection<\/li><li>hypersensitivity to human thrombin, any component of the product, or hamster proteins<\/li><\/ul>"},{"id":"928972-s-3-10","title":"Precautions","mono":"<ul><li>hypersensitivity reactions, including anaphylaxis, may occur; product may contain hamster or snake proteins<\/li><li>systemic absorption; risk of thrombosis; do not inject<\/li><li>report adverse reactions to the US Food and Drug Administration at 1-800-FDA-1088 or www.fda.gov\/medwatch<\/li><\/ul>"},{"id":"928972-s-3-11","title":"Pregnancy Category","mono":"Thrombin: C (FDA)<br\/>"},{"id":"928972-s-3-12","title":"Breast Feeding","mono":"Thrombin: Micromedex: Infant risk cannot be ruled out.<br\/>"}]},"5":{"id":"928972-s-5","title":"Adverse Effects","mono":"<b>Serious<\/b><br\/><b>Hematologic:<\/b>Thromboembolic disorder (1% to 9%)<br\/>"},"6":{"id":"928972-s-6","title":"Drug Name Info","sub":{"0":{"id":"928972-s-6-17","title":"US Trade Names","mono":"Recothrom<br\/>"},"2":{"id":"928972-s-6-19","title":"Class","mono":"Hemostatic<br\/>"},"3":{"id":"928972-s-6-20","title":"Regulatory Status","mono":"RX<br\/>"},"4":{"id":"928972-s-6-21","title":"Generic Availability","mono":"No<br\/>"}}},"7":{"id":"928972-s-7","title":"Mechanism Of Action","mono":"Thrombin is a coagulation protein that clots the fibrinogen of the blood directly without the aid of a physiological agent. It is a highly specific protease that converts fibrinogen into fibrin. Thrombin human, recombinant is made by recombinant DNA technology from a genetically modified Chinese hamster ovary cell line without additives of human or animal origin.<br\/>"},"8":{"id":"928972-s-8","title":"Pharmacokinetics","sub":{"1":{"id":"928972-s-8-24","title":"Distribution","mono":"absent <br\/>"},"2":{"id":"928972-s-8-25","title":"Metabolism","mono":"rapidly inactivated in the blood (5 min) <br\/>"}}},"9":{"id":"928972-s-9","title":"Administration","mono":"<b>Topical<\/b><br\/><ul><li>for topical use only, not for injection<\/li><li>reconstitute using the supplied diluent at room temperature; avoid excessive agitation; product should dissolve in less than 1 minute<\/li><li>label the syringe bearing the reconstituted solution with the supplied preprinted label<\/li><li>if using with absorbable gelatin sponge(s), apply the soaked sponge(s) to the bleeding site in a single layer<\/li><li>vials are for single use only<\/li><\/ul>"},"10":{"id":"928972-s-10","title":"Monitoring","mono":"hemostasis within 10 minutes indicates clinical efficacy<br\/>"},"11":{"id":"928972-s-11","title":"How Supplied","mono":"<b>Recothrom<\/b><br\/>Topical Powder for Solution: 5000 IU, 20000 IU<br\/>"},"13":{"id":"928972-s-13","title":"Clinical Teaching","mono":"<ul><li>Drug may cause thromboembolic events.<\/li><li>Advise patient to report signs\/symptoms of an allergic reaction.<\/li><li>Instruct patient to report signs\/symptoms of thrombosis (eg, leg tenderness or selling, chest pain, shortness of breath, or difficulty speaking or swallowing).<\/li><\/ul>"}}}